Is Biperiden registered with the SFDA?

The SFDA human drug list (edition 4-2026, as published by the Council of Health Insurance) lists 0 valid registrations of Biperiden.

Is Biperiden approved by the US FDA?

Drugs@FDA lists 2 application product lines for Biperiden, including AKINETON (Discontinued); AKINETON (Discontinued).

Is Biperiden on the WHO Model List of Essential Medicines?

Yes — 5.1.3. Medicines for parkinsonism (core list): Parkinson disease.

Active substance

Biperiden

SFDA 3
US FDA 2
WHO EML 1

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade name	Strength	Form · route	Pack	Public price	Type	Company	Status
AKINETON 2MG TAB	2 mg	Tablet · Oral use	50 Blister	SAR 20.85	NCE · Prescription	Abbott Laboratories	Withdrawn by MAH · Not Marketed
AKINETON 5MG-ML AMP	5 mg/ml	Injection · Parenteral use	5 Ampoule	SAR 14.35	NCE · Prescription	Abbott Laboratories	Withdrawn by MAH · Not Marketed
AKINETON RETD. 4MG TAB	4 mg	Tablet · Oral use	20 Blister	SAR 22.15	NCE · Prescription	Abbott Laboratories	Withdrawn by MAH · Not Marketed

US FDA United States — FDA approvals (Drugs@FDA)

Product	Strength	Form · route	Applicant	Status	First approved
AKINETON	2MG	tablet · oral	ABBVIE	Discontinued	8 Sep 1959
AKINETON	5MG/ML	injectable · injection	ABBVIE	Discontinued	20 Apr 1961

WHO WHO Model List of Essential Medicines (2025)

5.1.3. Medicines for parkinsonism · core
Parkinson disease
Parenteral > General injections > IV: 5 mg per mL in 1 mL ampoule (lactate) | Oral > Solid: 2 mg tablet (hydrochloride)

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.